Seoul, South Korea

Ewha Womans University

www.ewha.ac.kr
Seoul, South Korea

Ewha Womans University is a private women's university in central Seoul, South Korea founded in 1886 by the American Methodist Episcopal missionary Mary F. Scranton. It is currently the world's largest female educational institute and is one of the most prestigious universities in South Korea.While the lack of an apostrophe in "Womans University" is unconventional, the use of "Woman's" rather than "Women's" was normal in the past.Τhe use of "Womans" carries special meaning. The early founders of the college thought that every woman in this community is worth being respected; to promote this idea, they chose the word "woman" to avoid lumping students together under the word "women." REDIRECT Template:Unreliable source?This is a redirect from a page that has been moved . This page was kept as a redirect to avoid breaking links, both internal and external, that may have been made to the old page name. For more information follow the category link.↑ ↑ ↑ Wikipedia.


Time filter

Source Type

Patent
Ewha Womans University and Aminologics Co. | Date: 2015-02-17

The present disclosure relates to a t-butylketone binaphthol derivative and a method of preparing the same, the t-butylketone binaphthol derivative being a high-efficiency chiral extracting agent which has a very high chiral selectivity enabling to extract an amino acid from an aqueous solution phase to an organic layer and to facilitate its hydrolysis, and enabling a continuous reuse of the organic layer.


Patent
Ewha Womans University | Date: 2015-06-16

Disclosed is a transimpedance amplifier. The transimpedance amplifier includes an inverter configured to have a feedback resistor and amplify a signal provided to an input side, and a common gate amplifier configured to be connected to the inverter in cascade and amplify an output of the inverter, wherein the signal provided to the input side is fed forward to a gate of the common gate amplifier through a gate resistor.


Patent
Ewha Womans University | Date: 2015-06-11

Disclosed is a differential transimpedance amplifier. The differential transimpedance amplifier includes a common gate amplifier configured to receive an electrical signal from an input node, and a common source amplifier configured to have a feedback resistor and receive the electrical signal form the input node, wherein an output signal of the common gate amplifier and an output signal of the common source amplifier form a differential signal pair.


The present invention relates to a CZTSe-based composite thin film, a method for preparing the CZTSe-based composite thin film, a solar cell using the CZTSe-based composite thin film, and a method for preparing the solar cell using the CZTSe-based composite thin film.


The present invention relates to a receptor-binding domain of an IgE-dependent histamine releasing factor (HRF), and a use thereof and, more specifically, ascertains, as an HRF framework region, an FL domain and an H2 domain which bind to a receptor of an HRF existing in a cell membrane, ascertains the C-terminus of the HRF, and ascertains that a material binding thereto inhibits IL-8 secretion, thereby determining that the FL and H2 domains and the C-terminus can be utilized in: the development of a therapeutic agent for and prevention of HRF-related diseases including malaria and inflammatory diseases such as asthma, bronchitis, chronic obstructive pulmonary disease, bronchiectasis, rhinitis, atopic dermatitis, hives, hay fever, conjunctivitis, anaphylactic allergic diseases, pneumonia, arthritis, nephritis, psoriasis, dermatitis, Crohns disease, enteritis, gingivitis, arteriosclerosis, coronary arteritis, hepatitis, Behcets disease, bladder cancer, prostatitis, pyelonephritis, glomerulonephritis, osteomyelitis, thyroiditis, uveitis, abdominal cavity inflammation, meningitis, pulmonary fibrosis and rheumatoid arthritis; and a method for screening for the HRF-related diseases.


Patent
Hyundai Motor Company, Kia Motors and Ewha Womans University | Date: 2016-07-05

The present disclosure provides a vehicle controller area network (CAN) communication attack detection method and apparatus. The apparatus includes: a learning module, a profiling module, and a detection module. The learning module identifies a CAN identifier (ID) upon receiving a predefined CAN packet and generates learning statistical information expressed as bits with respect to a data field corresponding to the identified CAN ID. The profiling module maintains the learning statistical information received and a precollected attack type, and the detection module extracts a CAN ID and a bit stream of a data field from a real-time input CAN packet. In addition, the detection module configures a neural network by acquiring the learning statistical information from the profiling module, inputs the extracted bit stream to the configured neural network, and determines whether attack is detected, based on an output value of the neural network.


Patent
Ewha Womans University and Korea University | Date: 2016-11-17

The present invention relates to a respirator without breathing resistance, which has an air inlet duct that passes through an inside and an outside of the respirator and that has asymmetrical electrodes and particle capturing plates formed on an inner surface of the air inlet duct; ozone removing element that removes ozone generated by micro-plasma; and high voltage dc-dc converter that provides high voltage to the asymmetrical electrodes. It employs asymmetrical electrodes and particle capturing plates to filter air without generating breathing resistance. When the respirator according to the present invention is used, safety of a wearer may be maintained in accordance with an environment and breathing may be smoothly performed even while introduction of pathogenic bacteria, viruses, fungi, spores, fine dust, or the like included in air may be effectively blocked. Accordingly, the respirator may be widely utilized to maintain the safety of the wearer in various environments.


The present invention relates to a receptor-binding domain of an IgE-dependent histamine releasing factor (HRF), and a use thereof, and more specifically, ascertains, as an HRF structual region, and a FL domain and an H2 domain which bind to a receptor of HRF existing in a cell membrane, ascertains the C-terminus domain of the HRF, and ascertains that a material binding thereto inhibits IL-8 secretion, thereby determining that the FL and H2 domains and the C-terminus domain can be utilized in: the development of a therapeutic agent for treatment and prevention of HRF-related disease including allergic diseases such as asthma, bronchitis, chronic obstructive pulmonary disease, bronchiectasis, rhinitis, atopic dermatitis, hives (urticaria), hay fever, conjunctivitis, and anaphylaxis; inflammatory diseases such as bronchitis, pneumonia, arthritis, nephritis, psoriasis, dermatitis, Crohns disease, enteritis, gingivitis, arteriosclerosis, coronary arteritis, hepatitis, Behcets disease, bladder cancer, prostatitis, pyelonephritis, glomerulonephritis, osteomyelitis, thyroiditis, uveitis, abdominal cavity inflammation, meningitis, pulmonary fibrosis and rheumatoid arthritis; and malaria, and a method for screening for the HRF-related diseases.


The present invention relates to a method for promoting the generation and secretion of extracellular vesicles from cells by using extracorporeal shockwave. More precisely, the inventors confirmed that the generation and secretion of extracellular vesicles from vascular endothelial cells were promoted by extracorporeal shockwave and further confirmed that siRNA can be transferred into cells without any help of a carrier. The inventors continued to find out that angiogenesis could be inhibited by introducing siRNA to an animal tumor model and succeeded to measure the size and amount of extracellular vesicles secreted by extracorporeal shockwave. Therefore, the present invention can be used in various fields since it can safely promote the generation and secretion of extracellular vesicles from cells.


You Y.,Ewha Womans University | Nam W.,Ewha Womans University
Chemical Society Reviews | Year: 2012

The development of cyclometalated Ir(III) complexes has enabled important breakthroughs in electroluminescence because such complexes permit the efficient population of triplet excited states that give rise to luminescent transitions. The triplet states of Ir(III) complexes are advantageous over those of other transition metal complexes in that their electronic transitions and charge-transfer characteristics are tunable over wide ranges. These favorable properties suggest that Ir(III) complexes have significant potential in a variety of photofunctions other than electroluminescence. In this critical review, we describe recent photonic applications of novel Ir(III) complexes. Ir(III) complexes have been shown to affect the exciton statistics in the active layers of organic photovoltaic cells, thereby improving the photon-to-current conversion efficiencies. Nonlinear optical applications that take advantage of the strong charge-transfer properties of triplet transitions are also discussed. The tunability of the electrochemical potentials facilitates the development of efficient photocatalysis in the context of water photolysis or organic syntheses. The photoredox reactivities of Ir(III) complexes have been employed in studies of charge migration along DNA chains. The photoinduced cytotoxicity of Ir(III) complexes on live cells suggests that the complexes may be useful in photodynamic therapy. Potential biological applications of the complexes include phosphorescence labeling and sensing. Intriguing platforms based on cyclometalated Ir(III) complexes potentially provide novel protein tagging and ratiometric detection. We envision that future research into the photofunctionality of Ir(iii) complexes will provide important breakthroughs in a variety of photonic applications. © 2012 The Royal Society of Chemistry.

Loading Ewha Womans University collaborators
Loading Ewha Womans University collaborators